Today: 9 April 2026
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

  • Wall Street opened lower as investors digested a fresh batch of earnings, lofty valuations, and policy uncertainty. The Dow, S&P 500 and Nasdaq all dipped at the open. Reuters
  • Private jobs data flashed weakness: Challenger reported 150k+ announced layoffs in October, the most for the month in 20+ years, sharpening focus on labor softness during the ongoing federal data blackout. Reuters
  • Rates & FX: The U.S. dollar fell for a second day as traders nudged up odds of a December Fed cut; bonds caught a bid. Reuters+1
  • Earnings movers: Qualcomm slipped on Samsung exposure risk; DoorDash fell on an investment pivot; Datadog and Moderna gained on upbeat results. Investing.com+3Reuters+3Reuters+3
  • Policy overhang: The Supreme Court signaled skepticism about the legality of President Trump’s tariff powers, a potential swing factor for trade and inflation in coming months. Reuters
  • Commodities: Oil edged up after hitting two‑week lows; gold firmed as a softer dollar and policy risks lifted haven demand. Reuters+1

Market snapshot

U.S. equities opened in the red Thursday, extending this week’s choppy pattern as investors weighed mixed corporate results against macro headwinds. At the bell, all three major indices slipped, with breadth tilting negative. The tone was cautious amid debate over still‑rich tech multiples and uncertain economic signals. Reuters

Overseas, European trading was subdued ahead of central‑bank cues, while Gulf markets tracked Asia modestly higher earlier in the day, helped by firmer regional catalysts and a tentative rebound in risk appetite. Reuters+1


The macro picture: weaker private labor signals in a data drought

With the government shutdown freezing several official releases, investors leaned on private indicators. Challenger, Gray & Christmas said U.S. employers announced more than 150,000 job cuts in October, the highest October tally in two decades. Cost cutting and AI adoption were cited among key drivers. That backdrop, plus broader uncertainty around tariffs and the shutdown, kept recession‑watchers and Fed‑watchers on edge. Reuters

Currency markets reacted quickly: the dollar slipped for a second day as traders marked up the probability of another Fed rate cut in December, and Treasuries rallied alongside haven bids elsewhere. Reuters+1


Tech skids again—yet some standouts shine

  • Qualcomm (QCOM): Shares fell after management flagged a potential loss of Samsung business next year, overshadowing better‑than‑expected guidance. The update amplified concern that AI‑linked leaders and their suppliers carry idiosyncratic customer‑concentration risks at stretched valuations. Reuters
  • DoorDash (DASH): The stock dropped as the company mapped out heavier investment plans, clouding the near‑term margin arc even as demand holds up. Reuters
  • Datadog (DDOG) and Moderna (MRNA): Both advanced in early trading after beating and raising outlooks—reinforcing the market’s preference for profitable growth and clean execution amid macro noise. Reuters+1

Zooming out, the week’s AI/megacap wobble has underscored just how reliant U.S. benchmarks remain on a narrow group of winners: small tremors there continue to propagate broadly. Reuters


Policy watch: tariff powers face a Supreme Court stress test

In a high‑stakes hearing, the U.S. Supreme Court appeared skeptical that the International Emergency Economic Powers Act gives the White House latitude to levy sweeping tariffs. A ruling against the administration could force a shift to other trade statutes and inject new uncertainty into near‑term tariff paths—potentially affecting prices, margins and Fed calculus. A decision is expected next year, but today’s tone added to market unease. Reuters


Rates, the dollar and gold

The greenback weakened for a second straight session as softer private labor indicators filtered through. Traders nudged December‑cut odds higher, while gold firmed on the combination of a weaker dollar and policy uncertainty. Longer‑dated yields eased in sympathy. Reuters+2Bloomberg Law+2


Energy: oil steadies after two‑week lows; Aramco trims Asia OSPs

Crude is nudging higher after a sharp slide to two‑week lows on Wednesday, with Brent and WTI ticking up as oversupply fears abate slightly. Separately, Saudi Aramco cut December official selling prices for Asia, a move consistent with softer demand and abundant supply across the barrel. Reuters+1


What to watch next

  • Fed speakers through the afternoon for hints on the December meeting path and how officials are interpreting private‑sector data amid the shutdown‑induced stats void. Reuters
  • Tesla shareholder vote on CEO Elon Musk’s record‑setting pay package—an event with potential read‑throughs for governance sentiment and mega‑cap risk appetite. Reuters
  • After‑the‑bell earnings from media, software and payments names for additional read‑throughs on consumer resilience, ad demand, and enterprise IT budgets. TradingView

The bottom line

November 6, 2025 is shaping up as another risk‑off session defined by tech fragility, labor‑market jitters, and policy fog. Bulls can point to stabilizing inflation and resilient services demand, but bears hold the near‑term narrative as earnings landmines, tariff litigation, and patchy jobs signals keep dip‑buying selective and disciplined. Reuters+1

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025
Previous Story

Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025

Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3
Next Story

Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Go toTop